Clinical Trial Update: A Study of HA121-28 Tablets in Patients With Medullary Thyroid Carcinoma (MTC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for HA121-28 tablets in medullary thyroid carcinoma, status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medullary Thyroid Carcinoma

Drugs mentioned

• HA121-28 tablets

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Medullary Thyroid Carcinoma | Phase 2 | Status: UNKNOWN